Lv0
0 积分 2023-12-11 加入
1392 EVOLVE-104, a novel ULBP2-targeted T cell engager that integrates CD2 costimulation for the treatment of basal and squamous lineage tumors
2小时前
已完结
The phospholipase A2 superfamily and its group numbering system
8个月前
已完结
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity
8个月前
已完结
Naturally occurring T cell mutations enhance engineered T cell therapies
9个月前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
1年前
已完结
皖公网安备34019202002308
